SandboxAQ has raised over $300 million in a funding round led by prominent investors, including Fred Alger Management, T. Rowe Price Associates, and Eric Schmidt, among others. The round values the company at $5.3 billion pre-money. The funding will accelerate the development of SandboxAQ’s Large Quantitative Models (LQMs) and other AI applications across industries such as drug discovery, materials science, cybersecurity, and healthcare. CEO Jack D. Hidary emphasized that LQMs have the potential to revolutionize sectors like biopharma, aerospace, and finance by solving complex challenges at scale. Notable supporters, such as AI scientist Yann LeCun and investors Jim Breyer and Eric Schmidt, praised the company’s ability to create value through AI technology.
In 2024, SandboxAQ made significant advancements, including breakthroughs in drug discovery, materials science, and aerospace navigation. The company’s AQBioSim division made strides in neurodegenerative disease therapies and expanded its partnerships with biopharma companies. Additionally, AQChemSim improved material design capabilities, while AQNav gained traction in aerospace for GPS-free navigation, securing a contract extension with the U.S. Air Force.
